Beyond Securities Public Company Limited (BYD) signed IPO Joint Distribution Agreement “BKGI”

Sitthiphat Sinfaphanit, Director of Investment Banking, Beyond Securities Public Company Limited “BYD” has participated in the contract signing ceremony as a co-underwriter of common stocks of Bangkok Genomics Innovation Public Company Limited “BKGI”

With an initial public offering (IPO) of 160 million shares at par value of 0.50 baht at the offering price of 1.63 baht per share. The IPO subscription starts on 12-14 March 2024. It is expected to enter the first day of trading on The Stock Exchange of Thailand (SET) on 20 March 2024. The securities abbreviation is “BKGI” under the Health Care Services (HELTH) business category.

Bangkok Genomics Innovation Public Company Limited, a subsidiary of BGI Genomics, operates laboratories and provides medical analysis services and received a licence to operate a medical facility from the Department of Health Service Support Ministry of Public Health in 2018. Examples of available services include screening for fetal chromosomal abnormalities from maternal blood using Non-Invasive Prenatal Testing (NIPT) and genetic screening for those who are planning to have children and infertility groups.

In addition, Bangkok Genomics Innovation Public Company Limited has supported various research in the medical field to promote scientific knowledge to clinics, hospitals and universities in Thailand as well.